Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Medtronic PLC    MDT   IE00BTN1Y115

MEDTRONIC PLC

(MDT)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Medtronic : 4Q Profit Falls on Higher Expenses, Restructuring Charge

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/23/2019 | 07:52am EDT

By Kimberly Chin

Medtronic PLC (MDT) said profit fell in the fourth quarter after it recorded slightly higher expenses and an $86 million restructuring charge in the quarter, compared with $7 million a year earlier.

For the fiscal quarter ended April 26, the medical device company's net income was $1.17 billion, or 87 cents a share, compared with $1.46 billion, or $1.07 a share, from a year ago. Analysts polled by Refinitiv were expecting $1.15 a share.

Excluding special items, Medtronic made an adjusted profit of $1.54 a share. Analysts forecasted $1.46 a share.

Sales were flat from a year ago, at $8.15 billion. Analysts expected $8.11 billion. U.S. revenue, which represents over half of Medtronic's total revenues, rose 2.3%, to $4.28 billion, from the same period last year.

Write to Kimberly Chin at kimberly.chin@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDTRONIC PLC
09/19MEDTRONIC : MiniMed 670G System European Real-World Data Shows 73% Time in Range..
AQ
09/18MEDTRONIC : Introduces Envision Pro Continuous Glucose Monitoring (CGM) System i..
AQ
09/18MEDTRONIC : MiniMed™ 670G System European Real-World Data Shows 73% Time i..
AQ
09/17MEDTRONIC : National Osteoporosis Foundation Supports New Evidence-Based Care Pa..
AQ
09/17MEDTRONIC : Introduces Envision™ Pro Continuous Glucose Monitoring (CGM) S..
AQ
09/16MEDTRONIC : Announces Robotic-Assisted Surgery Investor Update
AQ
09/16National Osteoporosis Foundation Supports New Evidence-Based Care Pathway Des..
GL
09/16MEDTRONIC : named a leading Sustainability Company
AQ
09/16MEDTRONIC : Named a Leading Sustainability Company Strong ESG Practices Results ..
AQ
09/16Medtronic and Novo Nordisk Enter Agreement to Provide Integrated Digital Solu..
GL
More news
Financials (USD)
Sales 2020 31 496 M
EBIT 2020 9 274 M
Net income 2020 5 412 M
Debt 2020 17 412 M
Yield 2020 1,89%
P/E ratio 2020 27,9x
P/E ratio 2021 24,5x
EV / Sales2020 5,29x
EV / Sales2021 4,92x
Capitalization 149 B
Chart MEDTRONIC PLC
Duration : Period :
Medtronic PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 117,62  $
Last Close Price 111,18  $
Spread / Highest target 19,6%
Spread / Average Target 5,79%
Spread / Lowest Target -10,1%
EPS Revisions
Managers
NameTitle
Omar S. Ishrak Chairman & Chief Executive Officer
Mark Ploof Senior Vice President-Global Operations
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Richard E. Kuntz Chief Scientific, Clinical & Regulatory Officer
Richard H. Anderson Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC22.23%149 167
BAXTER INTERNATIONAL INC.32.79%44 623
HOYA CORPORATION36.29%30 734
ZIMMER BIOMET HOLDINGS36.93%29 159
TERUMO CORP-44.16%23 360
ALIGN TECHNOLOGY-10.93%14 899